| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Executive Officer | See Remarks
2 companies
Turtle Cameron is a Chief Executive Officer at SYRE with holdings across 2 companies. Recent SEC Form 4 filings include 0 buys and 12 sells.
Estimated insider holdings value: $55.2M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Sep 30, 2020 | BBIO Bridgebio Pharma, Inc. | See Remarks | Sale+OE | 14,500 | $37.69 | $546,457.74 | -34.8% | |
| Sep 18, 2020 | BBIO Bridgebio Pharma, Inc. | See Remarks | Sale+OE | 2,500 | $42.01 | $105,024.25 | -16.6% | |
| Sep 15, 2020 | BBIO Bridgebio Pharma, Inc. | See Remarks | Sale+OE | 2,500 | $37.06 | $92,651.75 | -16.6% | |
| Sep 11, 2020 | BBIO Bridgebio Pharma, Inc. | See Remarks | Sale+OE | 2,000 | $35.02 | $70,047.00 | -13.7% | |
| Jun 30, 2020 | BBIO Bridgebio Pharma, Inc. | See Remarks | Sale+OE | 10,000 | $32.66 | $326,623.04 | -33.4% | |
| Apr 27, 2020 | BBIO Bridgebio Pharma, Inc. | See Remarks | Sale+OE | 2,000 | $32.01 | $64,027.60 | -16.9% | |
| Apr 8, 2020 | BBIO Bridgebio Pharma, Inc. | See Remarks | Sale+OE | 8,000 | $27.04 | $216,357.60 | -44.9% | |
| Feb 11, 2020 | BBIO Bridgebio Pharma, Inc. | See Remarks | Sale+OE | 2,000 | $37.28 | $74,564.20 | -16.9% | |
| Jan 8, 2020 | BBIO Bridgebio Pharma, Inc. | See Remarks | Sale+OE | 12,807 | $34.37 | $440,210.99 | -34.4% |